Interleukin 10 protects mice from lethal endotoxemia.
Open Access
- 1 April 1993
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 177 (4) , 1205-1208
- https://doi.org/10.1084/jem.177.4.1205
Abstract
Interleukin 10 (IL-10) decreases production of IL-1, IL-6, and tumor necrosis factor alpha (TNF-alpha) in vitro, and neutralization of IL-10 in mice leads to elevation of the same monokines. We test here whether this monokine-suppressing property of IL-10 confers on it the capacity to protect mice from lipopolysaccharide-induced shock, a monokine-mediated inflammatory reaction. A single injection of 0.5-1 microgram of recombinant murine IL-10 reproducibly protected BALB/c mice from a lethal intraperitoneal injection of endotoxin. This result was obtained whether the IL-10 was administered concurrently with, or 30 min after the injection of endotoxin. The protective effect of IL-10 was reversed by prior injection of neutralizing anti-IL-10 antibodies, and correlated with a substantial decrease in endotoxin-induced TNF-alpha release. These data implicate IL-10 as a candidate for treatment of bacterial sepsis, and more generally as an effective antiinflammatory reagent.Keywords
This publication has 21 references indexed in Scilit:
- Interleukin-10Current Opinion in Immunology, 1992
- Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10European Journal of Immunology, 1992
- Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.Proceedings of the National Academy of Sciences, 1992
- IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor.The Journal of Immunology, 1992
- Biological properties of interleukin 10Immunology Today, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPIDThe Lancet, 1985
- Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies.Proceedings of the National Academy of Sciences, 1985
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- Mechanisms of the Hemodynamic Effects of EndotoxinPhysiological Reviews, 1960